Inhaled and Intranasal Products Contract Service Providers Market, 2030

News provided by

Dec 07, 2020, 08:45 ET

DUBLIN, Dec. 7, 2020 /PRNewswire/ -- The "Inhaled and Intranasal Products Contract Service Providers Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The 'Inhaled and Intranasal Products: Contract Service Providers Market (Focus on Drugs and Drug Delivery Systems), 2020 - 2030' report features an extensive study of the current market landscape and future opportunities for the contract service providers focused on drugs and drug delivery systems. It features an in-depth analysis, highlighting the capabilities of various contract service providers engaged in this domain.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on parameters, such as overall pulmonary market, global intranasal drug market, cost of goods sold and outsourcing trends, we have provided an informed estimate of the likely evolution of the contract service providers market in the mid to long term, for the time period 2020-2030.

Amongst other elements, the report includes:

A detailed assessment of the overall landscape of companies offering contract and custom services for the inhaled and Intranasal drug development and manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, type of service provider (contract manufacturing organization and contract research organization), scale of operation (preclinical, clinical and commercial), location of headquarters, location of manufacturing facilities, type of drug molecule (small molecule and biologic), type of inhaled and intranasal related primary service(s) offered (development, manufacturing, analytical testing/services, device selection/optimization and fill/finish and packaging), type of inhaled and intranasal related secondary service(s) offered (process development, pre-formulation development, formulation development, pre-formulation manufacturing, formulation manufacturing, particle engineering, product characterization, extractable and leachable studies, stability testing and plume geometry measurement), type of formulation (powder, aerosol and liquid), type of dosage form (metered dose inhaler, dry powder inhaler, nebulizer, soft mist inhaler, nasal spray, nasal drops, nasal powder and others), route of administration (oral and intranasal inhalation) and installed capacity and batch size (if available).
A detailed assessment of the overall landscape of the companies offering contract services for the inhaled and intranasal drug delivery system manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, scale of operation (precommercial and commercial), location of headquarters, location of manufacturing facilities, type of inhaled and intranasal drug delivery system related service(s) offered (design, development, manufacturing, assembly, fill/finish and packaging), type of formulation (powder, aerosol and liquid) and type of drug delivery system used (metered dose inhaler, dry powder inhaler, nebulizer, nasal spray and others).
A competitiveness analysis of inhaled and intranasal drug product contract service providers across key geographical areas, featuring a four-dimensional bubble representation, taking into consideration service strength (number of services offered, type of formulation(s) offered and route of administration), manufacturing strength (type of drug molecule, scale of operation, number of manufacturing facilities), supplier strength (company size and its experience in this field) and company size (small-sized, mid-sized and large).
Tabulated profiles of some of the key contract manufacturers (shortlisted based on a proprietary criterion) that offer a diverse range of capabilities for the development, manufacturing and packaging of inhaled and intranasal drugs across North America, Europe and Asia-Pacific. Each profile features an overview of the company, along with information related to its financial performance (if available), service portfolio, products and intranasal related capabilities, type of drug molecule, type of dosage form, inhaled and intranasal products related manufacturing facilities, recent developments and an informed future outlook.
An analysis of the various partnerships related to inhaled and intranasal contract service providers, which have been established since 2015, based on several parameters, such as year of agreement, type of partnership (development agreements, manufacturing agreements, merger and acquisition, licensing agreement, commercialization, research and development agreements, service alliance, joint venture and other agreements), scale of operation (preclinical, clinical and commercial), type of inhaled and intranasal related service(s) offered (development, manufacturing, analytical testing/services and fill/finish and packaging), type of dosage form (metered dose inhalers, dry powder inhalers, nebulizers and others) and most active players. It also provides the regional distribution of the players involved in the collaborations.
A qualitative analysis highlighting the various factors that need to be taken into consideration by inhaled and intranasal product developers, while deciding whether to manufacture their respective products in-house or engage a contract service provider.
An estimate of the global, inhaled and intranasal product demand, based on the type of product (inhaled and intranasal), type of drug delivery system used (metered dose inhalers, dry powder inhalers, nebulizers and nasal sprays) and key geographical regions (North America, Europe and Asia-Pacific).
An insightful discussion on the impact of COVID-19 outbreak on the inhaled and intranasal service providers. In addition, it features various strategies that different companies have adopted/may adopt in order to mitigate the challenges affiliated to the current global crisis.

Key Questions Answered

Who are the leading contract service providers offering inhalable and intranasal products related services, across the world?
In which regions are majority of the inhaled and intranasal product related manufacturing facilities located?
What percentage of inhaled and intranasal manufacturing operations are outsourced?
Which partnership models are commonly adopted by stakeholders in this industry?
What is the impact of COVID-19 outbreak on inhaled and intranasal product services market?
What is the current, global demand for inhaled and intranasal products?
How is the current and future market opportunity likely to be distributed across key market segments?

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Inhaled And Intranasal Drug Product Service Providers: Market Landscape

5. Inhaled And Intranasal Drug Delivery System Manufacturing Service Providers: Market Landscape

6. Company Competitiveness Analysis

7. Inhaled And Intranasal Contract Manufacturing Service Providers In North America

8. Inhaled And Intranasal Contract Manufacturing Service Providers In Europe And Asia-Pacific

9. Partnerships And Collaborations

10. Make Versus Buy Decision Making

11. Demand Analysis

12. Market Forecast And Opportunity Analysis

13. Impact Of Covid-19 Pandemic On The Inhaled And Intranasal Service Providers Market

14. Conclusion

15. Executive Insights

16. Appendix 1: Tabulated Data

Companies Mentioned

3M
3P innovation
Actelion Pharmaceuticals
Aerami Therapeutics (formerly Dance Biopharm)
Aerosol Research and Engineering Laboratories
Akums Drugs & Pharmaceuticals
Alcami
Alpic Biotech
Altaris Capital Partners
Altimmune
Amneal Pharmaceuticals
Aptar Pharma
Arch Biopartners
Arcturus Therapeutics
ASM Aerosol-Service
Aspen Pharmacare
AstraZeneca
Atossa Therapeutics
Aurohealth
Basic Pharma
Battelle
Bespak
Beximco Pharmaceuticals
BioCare Group
Biofilms Research Center for Biointerfaces, Malmo University
Boehringer Ingelheim
Breath Therapeutics
Capsugel
Carclo Technical Plastics
Catalent
CF PharmTech
Charles River Laboratories
Chemic Laboratories
Chiesi Farmaceutici
Chromcore Lifesciences
Cirrus Pharmaceuticals
COC Farmaceutici
Colep
Confab
Consort Medical
Contract Pharmaceuticals
Creative Biolabs
Circassia
CrystecPharma
Curida
CytoAgents
Dalton Pharma Services
DFE Pharma
Doctor Pack
Dorizoe Lifesciences
DPT Laboratories
Dr. Reddy's Laboratories
DRK Pharma Solutions
Dwarkesh Pharmaceuticals
EKG Life Science Solutions
Elfin Drugs
Emmace Consulting
Ennaid Therapeutics
Ethris
Eurofins
Evoke Pharma
Evonik
Experic
Farbe Firma
FAMAR
Focus Inhalation
Forefront Medical Technology
Forest Laboratories
Genentech
Gerresheimer
Getron Pharmaceuticals
Gilead Sciences
GlaxoSmithKline
Global Pharma
Hikma Pharmaceuticals
Horizon Pharmaceuticals
Hovione
Humanigen
Iconovo
IIT Research Institute (IITRI)
Impopharma
Importfab
Inhalexpert
InhaTarget Therapeutics
Insmed
Intas Pharmaceuticals
Intertek
Invion
iPharma
ITC Farma
J Pharmaceuticals
Jabil
Jagotec
Janssen Pharmaceuticals
Johnson & Johnson
Kiel University
Kindeva Drug Delivery
King's College London
Kymos Pharma Services
Labiana Pharmaceuticals
Lamda Laboratories
Lannet Technologies
LEAX Group
Lepharm
Life Vision Healthcare
Lindal Group
Liquidia Technologies
Lomapharm
Lonza
Lovelace Biomedical
Lxir Medilabs (A unit of SMM Life Sciences)
M2M Pharmaceuticals
Macter International
Malmo University
MannKind
Mapaex
Maya Biotech
McMaster University
Medicair Bioscience Laboratories
Medicilon
Medlab Pharmaceuticals
MedPharm
Menarini Group
Merck
Micro-Sphere
MidasCare
Mipharm
MMG Healthcare
Moderna Therapeutics
Molex
Medicon Valley Inhalation Consortium (MVIC)
Mylan
Nanologica
Nanopharm
Napp Pharmaceuticals
Nelipak Healthcare Packaging
Nelson Laboratories
Nemera
Nephron Pharmaceuticals
Neurelis
Neurimmune
Newtec Pro Manufacturing
Next Breath
Nipro
Nitto Medic
Nivon Specialties
Noble
Novartis
One Pharma
Orion
Ote Pharma
Optinose
Paragon Nordic
PARI Pharma
PCI Pharma Services
Penta Arzneimittel
Pfizer
Pharma Stulln
Pharma Tech
PharmaCielo
Pharmaserve
Pharmaterials
PHAST (Acquired by Eurofins)
Phillips-Medisize
Pine Lake Laboratories
Polyphor
PPD Laboratories
Probiotec
Propeller Health
Proveris Scientific
Pulmatrix
PulmoFlow
Pursuit Pharma
Pushkar Pharma
Quotient Sciences
Recipharm
Renaissance Pharmaceuticals
Roche
Rommelag
Rubicon Research
S.R.Chemicals and Pharmaceuticals
SAFE Pharmaceutical
Salvat
Sandoz
Sanofi
Sciarra Laboratories
Seikagaku
Sentiss Pharma
Servier Pharmaceuticals
SHL Group
Simpler Consulting
SkyePharma
Smithers
Spicona
Stabicon Life Sciences
Stevanato Group
Summit Biosciences
Sunovion
Sunovion Pharmaceuticals
Synerlab
Takeda
Teva Pharmaceuticals
The Indian Pharmaceutical Association
The Ritedose Corporation
Theravance Biopharma
Tinuum
Toxikon
Trillium Health Care Products
UCB Pharma
Ultratech India
United Therapeutics
University of Birmingham
University of Copenhagen
University of Cyprus
University of Florida
University of Turku
Bausch Health (formerly Valeant Pharmaceuticals)
Vectura
ViralClear Pharmaceuticals (A subsidiary of BioSig Technologies)
Vinventions
Vivimed
West Coast Pharmaceutical
Westmed Medical Group

For more information about this report visit https://www.researchandmarkets.com/r/63lzod

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets